Phase 3 Study of EBI-005 in Dry Eye Disease
NCT01998802
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
670
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease (DED)
Interventions
DRUG:
Active Comparator EBI-005
DRUG:
Placebo Comparator
Sponsor
Eleven Biotherapeutics